I was not impressed with earnings. Although I have not listened to the call. 2 million more in service. How much product revenue was HEGO? 1m more in product sales. If HEGO is a 15m/yr company, then their contribution should be $3.75m did we get that? No deals have been announced since the merger.
The date of acquisition was May 22 or so, leaving 39 days for Hego results to be combined. The press release says Hego's revenues for that period was $2.3M. So 91/39 X $2.3m = $5.4M and $5.4M X 4 quarters = $21.6M. Chyron's revenues were $8.4M. So it looks to me ChyronHego will do close to $30M in sales in 2nd half 2013.
Approximate $.09 per share loss---loss attributable to
one time charges and expenses related to Hego acquisition---
Any loss for the June quarter should be largely discounted
in the current stock price---more important will be
future outlook expressed by management for
second half 2013 and beyond.
Am currently guessing that stock will continue to trade in a
$1.34-$1.64 range through September--potentially moving
higher in the October - December 2013 time frame to
perhaps $1.80 - $2.00---then hopefully higher
in 2014. Still, many risks however ---helpful
if one has steady nerves in current volatile market
Well a lucky guess--
Conference call should be upbeat.
For now I am sticking with my $.20 operating earnings per share
guesstimate for 2014--may increase this to $.22 after conference
ChyronHego could attract some institutional buying interest
in next few months---my previous guesses regarding price
target goals for next few years hopefully will be conservative..